Hepatitis diabetes



interferon in diabetes mellituspeople with diabetes are sick with hepatitis B, C, D. for Example, among insulin-dependent diabetics, the incidence of 8-10 times higher in comparison with the healthy population.

Patients with diabetes mellitus belong to a high risk of infection with viruses that cause hepatitis. This is determined by the parenteral severe load (frequent injections), weakening of the immune system, aided by the underlying disease, a significant number of asymptomatic virus.

the disease in patients with diabetes mellitus often have a anicteric and subclinical (asymptomatic) form.


hepatitis Treatment diabetes mellitus

Treatment involves a number of problems. The fact that diabetics need to be particularly strict control. This is due to the fact that many drugs can cause elevated blood glucose and carbohydrate metabolism decompensirovanny. To compensate for the level of glycemia requires additional monitoring of indicators of blood glucose.

Before treatment is required to make the General and biochemical analysis, coagu-logram, and indication of HCV-PHK by PCR. The mainstay of treatment for hepatitis C is a combination of two antiviral drugs - ribavirin and interferon-alpha. The last is contraindicated in decompensation of diabetes mellitus and requires care in its use. It also reduce the dose or cancel altogether if the patient develops decompensation of carbohydrate metabolism. In such cases, it may be monotherapy.

ribavirin diabetesAt the time of treatment can and should be used hepatoprotectors. Without having antiviral effect, they improve the functioning of the liver. It is also important to take immunomodulators that stimulate the immune system and help the body in fighting infection.

the Effectiveness of the treatment of viral hepatitis assess the blood counts (General, biochemical analysis), presence of HCV-PHK. The development of side effects shows General analysis of blood.

the Treatment of hepatitis is costly, and poorly tolerated by people suffering from diabetes. Therefore important to consult with an infectious disease physician about its feasibility.